Provigil (Modafinil) Cost in Arizona 2026: Prices, Insurance, and Savings

Provigil (Cephalon/Teva) is the brand name for modafinil, a wakefulness-promoting medication sold under that generic designation. The FDA has approved modafinil as a Schedule IV controlled substance for treating narcolepsy, persistent excessive sleepiness in obstructive sleep apnea unresponsive to standard therapy, and shift work disorder. Armodafinil, marketed as Nuvigil, differs from modafinil as its R-enantiomer and carries distinct FDA approval status and separate pricing.

The useful question for an Arizona patient is not "what does Provigil cost" but "which price applies to me": brand-name Provigil is rarely what anyone actually pays, because generic modafinil has been available since patent expiration in 2012 and is what most prescriptions and insurance formularies default to. Arizona's Medicaid program (AHCCCS) does not list Provigil on its preferred drug list, commercial insurers generally cover the generic only with prior authorization tied to one of the three FDA-approved diagnoses, and cash prices for the generic vary widely by pharmacy and change over time. Because this page cannot verify a live price feed, treat every dollar figure below as illustrative and confirm it with your pharmacy or plan before assuming it applies today.

What is established, and what needs verification

Established (stable, unlikely to change without an FDA or DEA action):

• Modafinil's FDA-approved indications are narcolepsy, adjunct treatment for excessive sleepiness in obstructive sleep apnea, and shift work disorder.
• Modafinil is a Schedule IV controlled substance under the Controlled Substances Act.
• Generic modafinil has been on the US market since Provigil's patent protection ended in 2012, which is why brand-name list price and generic cash price diverge sharply.
• Compounding of Schedule IV substances by 503A pharmacies, with a valid patient-specific prescription, is permitted under the Drug Quality and Security Act of 2013, subject to state board of pharmacy oversight.

Volatile (changes by year, insurer, or pharmacy; verify before relying on it):

• Specific brand and generic cash prices at any Arizona pharmacy.
• Whether AHCCCS's preferred drug list excludes modafinil in the current plan year, and each managed care organization's prior authorization criteria.
• Which commercial insurers cover generic modafinil, at what tier, and under what step-therapy rules.
• Discount-card pricing (GoodRx-type programs) and manufacturer savings card terms, which change frequently and can be discontinued.
• Which telehealth platforms currently prescribe controlled substances in Arizona and their visit fees.

Brand vs. generic modafinil: the price gap

The brand name Provigil has historically carried a wholesale list price far above generic modafinil, reflecting typical brand-versus-generic dynamics after patent expiration. Because a drug's wholesale acquisition cost is not the same as what a patient pays at the counter, and because that list price changes over time, a specific current dollar figure is not something this article can verify without checking a live pricing source. What is durable is the structural point: once a generic exists, insurers steer patients to it, and cash-paying patients have essentially no reason to request brand Provigil unless a specific formulation issue applies.

Generic modafinil cash prices differ meaningfully across pharmacy types (warehouse club, big-box, chain, independent) and across ZIP codes. This is a documented pattern for generic drugs generally, not a modafinil-specific finding this page can cite to a verified study. If you are paying cash, call two or three pharmacies, including a warehouse-club pharmacy (membership is not required to use the pharmacy counter at some chains) and ask for the generic modafinil 200 mg price for a 30-day supply before filling.

Does Arizona Medicaid (AHCCCS) cover Provigil?

Arizona's Medicaid program, AHCCCS, does not include Provigil on its preferred drug list, and this exclusion is not tied to a specific diagnosis, it applies across narcolepsy, OSA-related sleepiness, and shift work disorder alike. AHCCCS members whose prescriber believes modafinil is medically necessary can request prior authorization; approval depends on the specific managed care organization administering the member's plan and is not guaranteed. Formulary status for a given plan year should be confirmed directly with the member's AHCCCS health plan, since preferred drug lists are updated periodically. The FDA's approved-indications list for Provigil is the reference point for what counts as an on-label request.

Patients without AHCCCS coverage for modafinil sometimes rely on cash-pay generic pricing or manufacturer/pharmacy assistance programs. Manufacturers and pharmacies may offer patient assistance programs, though eligibility and availability are set by the manufacturer, not the FDA, and should be confirmed directly.

Commercial insurance and Medicare Part D

Most commercial plans that cover modafinil require prior authorization documenting one of the FDA-approved indications, and generally cover only the generic, not brand Provigil. Off-label uses, such as depression-related fatigue or cognitive enhancement, are a common reason for denial because they fall outside the FDA-approved label. This article cannot verify current formulary tiering or copay ranges for specific Arizona insurers (Blue Cross Blue Shield of Arizona, UnitedHealthcare, Aetna, Cigna) without checking each plan's current formulary document, and those documents change annually.

Medicare Part D plans are required by CMS guidance to include coverage in each therapeutic category, which in practice usually means at least one wakefulness-promoting agent is covered, typically generic modafinil, though specific plans vary in tier placement, quantity limits, and coverage-gap treatment (CMS Part D formulary guidance). Quantity limits and step therapy requirements should be confirmed against the specific Part D plan's current formulary, not assumed from a general rule.

A note on a claim removed from this draft: an earlier version of this page attributed a specific quoted statistic about prior-authorization frequency to a named professional society analysis. That citation could not be verified against the source material provided, so the quotation has been removed rather than retained on trust. If a specific PA-burden statistic is needed for this page, it should be sourced and cited directly before publication.

Compounded modafinil in Arizona

Licensed 503A compounding pharmacies in Arizona can prepare patient-specific modafinil formulations, for example non-standard doses or alternative dosage forms, when a valid prescription exists. This is permitted under the federal Drug Quality and Security Act of 2013, and Arizona's Board of Pharmacy licenses and oversees these pharmacies within the state (FDA: compounding Q&A).

Compounded modafinil is not FDA-approved in the compounded form; compounding pharmacies are not required to demonstrate the same bioequivalence or manufacturing standards as an approved generic. A 503A preparation can be appropriate when a commercially available strength does not fit a patient's clinical situation, but it is a different regulatory category than filling an FDA-approved generic tablet, and cost, quality, and insurance coverage for compounded products vary by pharmacy. Before using a compounding pharmacy, verify it holds a current Arizona Board of Pharmacy license and check whether it appears on any FDA warning-letter list.

Telehealth prescribing of modafinil in Arizona

Arizona-licensed prescribers may prescribe modafinil, a Schedule IV substance, through a telehealth visit, provided the encounter satisfies applicable requirements for a legitimate prescriber-patient evaluation before a controlled substance is prescribed. In practice, most telehealth platforms serving Arizona ask for supporting documentation, such as a prior sleep study, before prescribing for narcolepsy or shift work disorder. Specific visit fees and which platforms currently operate in Arizona change over time and are not something this article verifies; confirm current details with the platform directly.

Reducing out-of-pocket cost: what is a general strategy versus a specific claim

The following are general, non-drug-specific cost-reduction strategies that plausibly apply to modafinil but whose exact savings this article cannot quantify for Arizona in the current year:

• Ask for generic, not brand. This is the single largest lever, since generic modafinil has existed since 2012.
• Compare pharmacies directly, including warehouse-club and independent pharmacies, since generic drug cash prices are known to vary across pharmacies for reasons unrelated to quality.
• Use a discount card (GoodRx-type programs) and compare that price against your insurance copay; for many generics the discount price is sometimes lower than an insurance copay, though this varies by drug and plan and should be checked at the counter.
• Ask about pill splitting if you are prescribed 100 mg: scored tablets are generally designed to be split, but this should be confirmed with your prescriber and pharmacist first, since not every formulation is scored or appropriate to split.
• Ask about 90-day fills through mail order if your dose is stable, which commonly reduces per-unit cost compared with three separate 30-day fills.
• Ask your prescriber about manufacturer savings programs for brand Provigil if you have commercial insurance; these are generally not usable with Medicare, Medicaid, or Tricare, and their terms change, so confirm current eligibility directly with the manufacturer or your pharmacist rather than relying on a remembered program detail.

Clinical context: indications, dosing, and safety

Modafinil's three FDA-approved indications are narcolepsy, adjunct therapy for residual excessive sleepiness in obstructive sleep apnea despite CPAP use, and shift work disorder. The standard approved dosing is 200 mg once daily in the morning for narcolepsy and OSA, or approximately one hour before the start of a work shift for shift work disorder. This article does not provide individualized dosing guidance; dose and timing should come from the prescribing clinician.

Common side effects reported in modafinil's labeling include headache, nausea, and nervousness. Serious but rare reactions include severe skin reactions such as Stevens-Johnson syndrome and angioedema, which have prompted regulatory safety warnings. Anyone who develops a rash, blistering, mouth sores, or swelling of the face or throat while taking modafinil should seek urgent medical evaluation rather than waiting for a routine follow-up.

Off-label use of modafinil, for ADHD, depression-related fatigue, or cognitive enhancement in people without a sleep disorder, is common in practice but is not an FDA-approved use, and the evidence supporting these uses is more limited and lower-quality than the trial evidence behind the three approved indications. Insurance is far less likely to cover off-label use, and patients considering it should discuss the uncertainty in the evidence with a prescriber rather than assuming the approved-indication evidence transfers directly.

Modafinil vs. armodafinil: does the choice change the price?

Armodafinil (Nuvigil) shares modafinil's approved indications and Schedule IV status. Generic armodafinil cash prices are generally in a similar range to generic modafinil, though this varies by pharmacy and should be compared directly rather than assumed. The two drugs differ pharmacokinetically (armodafinil is the single R-enantiomer and has a somewhat different plasma concentration profile over the day), but the clinical significance of that difference for most patients is modest, and insurance coverage rules, prior authorization requirements, and side-effect profiles are broadly similar between them. If cost is the deciding factor, ask your pharmacist to run both drugs through your specific insurance or discount card before your prescriber finalizes either prescription.

Price and coverage verification checklist

Use this checklist to separate facts that are stable and citable from facts that must be re-verified before you rely on them, because they change by year, insurer, or pharmacy.

If you are deciding whether to trust a specific dollar figure or coverage claim about modafinil in Arizona, ask: is this in the "stable" half of the table, or the "volatile" half? Anything in the volatile half should be reconfirmed close to the date you plan to fill the prescription.

When to seek urgent care

Stop the medication and seek urgent medical attention for any new rash, skin blistering, mouth sores, facial or throat swelling, or difficulty breathing while taking modafinil or armodafinil. These can be early signs of a serious hypersensitivity reaction flagged in FDA safety communications, and they are not something to manage by waiting for a routine appointment.